Growth Metrics

Tvardi Therapeutics (TVRD) Payables: 2013-2015

Historic Payables for Tvardi Therapeutics (TVRD) over the last 3 years, with Dec 2015 value amounting to $5.3 million.

  • Tvardi Therapeutics' Payables rose 170.71% to $5.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was $14.3 million, marking a year-over-year increase of 29.85%. This contributed to the annual value of $5.3 million for FY2015, which is 170.71% up from last year.
  • As of FY2015, Tvardi Therapeutics' Payables stood at $5.3 million, which was up 170.71% from $1.9 million recorded in FY2014.
  • In the past 5 years, Tvardi Therapeutics' Payables registered a high of $5.3 million during FY2015, and its lowest value of $1.9 million during FY2014.
  • In the last 3 years, Tvardi Therapeutics' Payables had a median value of $2.0 million in 2013 and averaged $3.1 million.
  • Per our database at Business Quant, Tvardi Therapeutics' Payables fell by 0.61% in 2014 and then spiked by 170.71% in 2015.
  • Yearly analysis of 3 years shows Tvardi Therapeutics' Payables stood at $2.0 million in 2013, then dropped by 0.61% to $1.9 million in 2014, then skyrocketed by 170.71% to $5.3 million in 2015.